Bone mineral density analyses using Dual Energy X-Ray Absorptiometry (DXA) in breast cancer patients receiving aromatase inhibitor treatment
Medical Services Advisory Committee
Record ID 32015000578
English
Authors' recommendations:
This proposal is for the provision of an MBS item for bone densitometry by DXA for women with breast cancer who receive, or are being considered for, treatment with aromatase inhibitors.
Details
Project Status:
Completed
Year Published:
2014
URL for published report:
http://www.msac.gov.au/internet/msac/publishing.nsf/Content/1313-public
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Australia
MeSH Terms
- Bone Density
- Aromatase Inhibitors
- Breast Neoplasms
Contact
Organisation Name:
Medical Services Advisory Committee
Contact Address:
MSAC (MDP 107), GPO Box 9848, Canberra, ACT 2601, Australia. Tel: +61 2 6289 6811; Fax: +61 2 6289 8799.
Contact Name:
msac.secretariat@health.gov.au
Contact Email:
msac.secretariat@health.gov.au
Copyright:
Medical Services Advisory Committee (MSAC)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.